ZIMMER BIOMET HOLDINGS INC (ZBH) Stock Price, Forecast & Analysis
NYSE:ZBH • US98956P1021
ZBH Key Statistics, Chart & Performance
The current stock price of ZBH is 99.46 USD. In the past month the price increased by 14.85%. In the past year, price decreased by -4.66%.
ZBH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to ZBH. When comparing the yearly performance of all stocks, ZBH is a bad performer in the overall market: 67.37% of all stocks are doing better.
ZBH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ZBH. While ZBH has a great profitability rating, there are quite some concerns on its financial health.
ZBH Financial Highlights
Over the last trailing twelve months ZBH reported a non-GAAP Earnings per Share(EPS) of 8.2. The EPS increased by 2.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.56% | ||
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| Debt/Equity | 0.55 |
ZBH Forecast & Estimates
34 analysts have analysed ZBH and the average price target is 104.39 USD. This implies a price increase of 4.95% is expected in the next year compared to the current price of 99.46.
For the next year, analysts expect an EPS growth of 4.45% and a revenue growth 4.16% for ZBH
ZBH Ownership
ZBH Latest News, Press Relases and Analysis
ZBH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 20.08 | 195.119B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.15 | 179.003B | ||
| SYK | STRYKER CORP | 25.44 | 145.408B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.23 | 110.604B | ||
| BDX | BECTON DICKINSON AND CO | 11.7 | 52.82B | ||
| IDXX | IDEXX LABORATORIES INC | 42.06 | 50.758B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.73 | 46.296B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.7 | 38.388B | ||
| RMD | RESMED INC | 21.24 | 37.749B | ||
| DXCM | DEXCOM INC | 29.02 | 28.503B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ZBH
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Company Info
ZIMMER BIOMET HOLDINGS INC
345 E Main St
Warsaw Indiana INDIANA 46580 US
CEO: Bryan Hanson
Employees: 17000
Phone: 15742676131
ZIMMER BIOMET HOLDINGS INC / ZBH FAQ
Can you describe the business of ZIMMER BIOMET HOLDINGS INC?
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana. The company went IPO on 2001-07-25. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. The company also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Can you provide the latest stock price for ZIMMER BIOMET HOLDINGS INC?
The current stock price of ZBH is 99.46 USD. The price increased by 0.72% in the last trading session.
Does ZBH stock pay dividends?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a dividend yield of 1.04%. The yearly dividend amount is currently 0.96.
How is the ChartMill rating for ZIMMER BIOMET HOLDINGS INC?
ZBH has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is ZIMMER BIOMET HOLDINGS INC (ZBH) stock traded?
ZBH stock is listed on the New York Stock Exchange exchange.
What is the employee count for ZBH stock?
ZIMMER BIOMET HOLDINGS INC (ZBH) currently has 17000 employees.
Can you provide the short interest for ZBH stock?
The outstanding short interest for ZIMMER BIOMET HOLDINGS INC (ZBH) is 4.95% of its float.